(Q35970409)

11 August 2017

1 reference

title

Cysteine cathepsins in human cancer (English)

1 reference

11 August 2017

Christopher Jedeszko

1

1 reference

11 August 2017

Bonnie F Sloane

series ordinal

2

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

385

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

1017-1027

1 reference

Cysteine proteases as disease markers

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cathepsin K mRNA and protein expression in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cathepsin K expression in human lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Decreased activity of cathepsins L+B and decreased invasive ability of PC3 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cathepsin B and glioma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Invasion of melanoma cells into dermal connective tissue in vitro: evidence for an important role of cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Expression of cathepsins B and S in the progression of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

The clinical significance of cathepsin S expression in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Unraveling the role of proteases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Lysosomal enzymes, cathepsins in brain tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Molecular mechanisms of glioma invasiveness: the role of proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Pericellular cathepsin B and malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Expression and the role of cathepsin H in human glioma progression and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Expression of cysteine protease inhibitors in human gliomas and meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Lysosomal cysteine proteases: facts and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Increased activity of cathepsin B in fibroblasts isolated from primary melanoma in comparison to fibroblasts from normal skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Analysis of a truncated form of cathepsin H in human prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Molecular regulation of human cathepsin B: implication in pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Expression of cathepsin B and cystatin C in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.132

21 January 2018

Identifiers

DOI

10.1515/BC.2004.132

1 reference

11 August 2017

1 reference